BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26106267)

  • 1. Bioinformatics Data Mining Approach Suggests Coexpression of AGTPBP1 with an ALS-linked Gene C9orf72.
    Kitano S; Kino Y; Yamamoto Y; Takitani M; Miyoshi J; Ishida T; Saito Y; Arima K; Satoh J
    J Cent Nerv Syst Dis; 2015; 7():15-26. PubMed ID: 26106267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular network analysis suggests a logical hypothesis for the pathological role of c9orf72 in amyotrophic lateral sclerosis/frontotemporal dementia.
    Satoh J; Yamamoto Y; Kitano S; Takitani M; Asahina N; Kino Y
    J Cent Nerv Syst Dis; 2014; 6():69-78. PubMed ID: 25210488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Immune Activation by
    Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
    Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Models of
    Batra R; Lee CW
    Front Cell Neurosci; 2017; 11():196. PubMed ID: 28729824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD.
    Freibaum BD; Taylor JP
    Front Mol Neurosci; 2017; 10():35. PubMed ID: 28243191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
    Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
    Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal Transcriptome from
    Liu EY; Russ J; Lee EB
    Free Neuropathol; 2020; 1():. PubMed ID: 32905541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.
    Martier R; Liefhebber JM; García-Osta A; Miniarikova J; Cuadrado-Tejedor M; Espelosin M; Ursua S; Petry H; van Deventer SJ; Evers MM; Konstantinova P
    Mol Ther Nucleic Acids; 2019 Jun; 16():26-37. PubMed ID: 30825670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic neurites express C9orf72 in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Alzheimers Res Ther; 2012 Aug; 4(4):33. PubMed ID: 22898310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology.
    Diab R; Pilotto F; Saxena S
    Front Cell Neurosci; 2023; 17():1086895. PubMed ID: 37006471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Role of RNA Mediated Toxicity of
    Kumar V; Hasan GM; Hassan MI
    Front Neurosci; 2017; 11():711. PubMed ID: 29326544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.